Nicotine replacement therapies

Medical drug manufacturer Qnovia announced the first human trial results of its inhalation smoking cessation therapy QN-01.

Organigram Holdings Inc's CFO, Derrick West, will step down for health reasons, with Paolo De Luca serving as temporary CFO.

India's 100 million smokers, responsible for over 20% of tobacco-related deaths globally, could benefit from increased access to Nicotine Replacement Therapy (NRT).

France's health minister plans to allow pharmacists to prescribe e-cigarettes as nicotine replacements, but not disposable ones.

The American Vaping Association advocates for mint-flavored e-cigarette products to replace mint cigarettes banned by the FDA.

Global nicotine replacement therapy market is set to reach $103.4 billion by 2028 with a CAGR of 15.1%. Key players include Pfizer, J&J, and GlaxoSmithKline.

Traditional smoking has declined in the UK by 52% in 6 years, with only 1.8% successfully quitting through the NHS. Electronic cigarettes offer new opportunities.